Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.

Liberati, A M; Horisberger, M A; Garofani, P; De Angelis, V; Ferrajoli, A; Di Clemente, F; Caricchi, P; Adiuto, D; Fedeli, L; Palumbo, B

Liberati, A M; Horisberger, M A; Garofani, P; De Angelis, V; Ferrajoli, A; Di Clemente, F; Caricchi, P; Adiuto, D; Fedeli, L; Palumbo, B.

Affiliation

Liberati AM; Istituto di Medicina Interna e Scienze Oncologiche, Policlinico Monteluce Perugia, Italy.

J Interferon Res ; 14(6): 349-55, 1994 Dec.

Article in En | MEDLINE | ID: mdl-7897254

Subject(s)

Adenosine Monophosphate/blood; Biopterins/analogs & derivatives; Immunologic Factors/pharmacology; Interferon-alpha/pharmacology; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy; beta 2-Microglobulin/metabolism; Adult; Aged; Antiviral Agents/biosynthesis; Biopterins/blood; Female; GTP-Binding Proteins/biosynthesis; Humans; Interferon alpha-2; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood; Male; Middle Aged; Myxovirus Resistance Proteins; Neopterin; Protein Biosynthesis; Recombinant Proteins

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Biopterins / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Adenosine Monophosphate / Beta 2-Microglobulin / Interferon-alpha / Immunologic Factors Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 1994 Type: Article

Search on Google

XML

PubMed Links